相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease
Tian-Jing Liu et al.
MOLECULAR MEDICINE REPORTS (2016)
Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT)
Ronnie Ramadan et al.
AMERICAN HEART JOURNAL (2016)
Olmesartan Prevented Intra-articular Inflammation Induced by Zymosan in Rats
Gerlane Coelho Bernardo Guerra et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Captopril pretreatment protects the lung against severe acute pancreatitis induced injury via inhibiting angiotensin II production and suppressing Rho/ROCK pathway
Qi-Hong Yu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2016)
Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver
Hasan Mahmud Reza et al.
TOXICOLOGY MECHANISMS AND METHODS (2016)
Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver
Hasan Mahmud Reza et al.
TOXICOLOGY MECHANISMS AND METHODS (2016)
Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
Shahinul Alam et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2016)
Activation of the Renin-Angiotensin System Promotes Colitis Development
Yongyan Shi et al.
SCIENTIFIC REPORTS (2016)
Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155 pathway
Yi Li et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats
Mariam Gamal Fahmy Wahba et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Captopril inhibits maturation of dendritic cells and maintains their tolerogenic property in atherosclerotic rats
Hong-qi Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss
C. M. Queiroz-Junior et al.
JOURNAL OF PERIODONTAL RESEARCH (2015)
Telmisartan decreases inflammation by modulating TNF-α, IL-10, and RANK/RANKL in a rat model of ulcerative colitis
Gerlane C. B. Guerra et al.
PHARMACOLOGICAL REPORTS (2015)
Effects of Olmesartan on Endothelial Progenitor Cell Mobilization and Function in Carotid Atherosclerosis
Yong Zou
MEDICAL SCIENCE MONITOR (2015)
The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure
Irving H. Zucker et al.
CLINICAL SCIENCE (2014)
Effect of candesartan on the expression of sclera-choroidal intercellular adhesion molecule-1 in hypercholesterolemic models
Rogil Jose de Almeida Torres et al.
CLINICS (2014)
A Combination of Low-Dose Fluvastatin and Valsartan Decreases Inflammation and Oxidative Stress in Apparently Healthy Middle-Aged Males
Miodrag Janic et al.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2014)
Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice
Changhyun Lee et al.
LIFE SCIENCES (2014)
Treatment of Primary Chronic Glomerulonephritis with Rehmannia Glutinosa Acteosides in Combination with the Angiotensin Receptor Blocker Irbesartan: A Randomized Controlled Trial
HongYu Qiu et al.
PHYTOTHERAPY RESEARCH (2014)
Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE-/- Mice: Molecular Imaging with 14C-FDG and 99mTc-Annexin A5
Yan Zhao et al.
PLOS ONE (2014)
Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease
Hany H. Arab et al.
PLOS ONE (2014)
Therapeutic effect of Captopril on rheumatoid arthritis in rats
Hong-Mei Liu et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2014)
Concepts of tissue injury and cell death in inflammation: a historical perspective
David Wallach et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Gender and racial differences in nonalcoholic fatty liver disease
Jen-Jung Pan et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan
Najah R. Hadi et al.
CARDIOVASCULAR THERAPEUTICS (2013)
TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor - Fosinopril
Shuansuo Yang et al.
CELLULAR IMMUNOLOGY (2013)
Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement
Neha Jadeja Pagidipati et al.
CIRCULATION (2013)
Angiotensin Converting Enzyme-Inhibitor Reduces Colitis Severity in an IL-10 Knockout Model
Ryo Sueyoshi et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats
Rowaida Refaat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effects of Irbesartan on Inflammatory Cytokine Concentrations in Patients with Chronic Glomerulonephritis
Shuichi Tsuruoka et al.
INTERNAL MEDICINE (2013)
Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis
Di Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
The role of angiotensin II in nonalcoholic steatohepatitis
E. Matthew Morris et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
Katia D. Silveira et al.
PEPTIDES (2013)
Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats
Marvva M. Nagib et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
Carlos Sostres et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: Evaluation by intravascular ultrasound) extension trial
Atsushi Hirohata et al.
ATHEROSCLEROSIS (2012)
Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor
Hideto Yano et al.
CIRCULATION JOURNAL (2012)
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
Roberto Fogari et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: Comparative analysis with rosuvastatin alone by intravascular ultrasound
Seung Hwan Han et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis
Qin Shi et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Simvastatin and Losartan Differentially and Synergistically Inhibit Atherosclerosis in Apolipoprotein E-/- Mice
Bok-Soo Lee et al.
KOREAN CIRCULATION JOURNAL (2012)
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits
Ya-pei Yang et al.
ACTA PHARMACOLOGICA SINICA (2011)
Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis
N. Schlimmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation
Shinya Kuwashiro et al.
CELL AND TISSUE RESEARCH (2011)
Use of Enterally Delivered Angiotensin II Type Ia Receptor Antagonists to Reduce the Severity of Colitis
Manabu Okawada et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function and Atherosclerosis in Japanese Patients with Mild-to-Moderate Hypertension (J-ELAN) study
Kazuhiro Yamamoto et al.
HYPERTENSION RESEARCH (2011)
Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety
Addison A. Taylor et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial
Hisashi Hidaka et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis
Luigi Villa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production
K. Shimada et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Valsartan alleviates atherosclerotic lesions in pulmonary arteries of rabbits via an endothelium-dependent mechanism
Yuanshi Li et al.
ACTA CARDIOLOGICA (2010)
Effects of Paricalcitol and Enalapril on Atherosclerotic Injury in Mouse Aortas
Kazim Husain et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Involvement of the Renin-Angiotensin System in the Development of Vascular Damage in a Rat Model of Arthritis Effect of Angiotensin Receptor Blockers
Takeo Sakuta et al.
ARTHRITIS AND RHEUMATISM (2010)
Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells
Chunjie Han et al.
ATHEROSCLEROSIS (2010)
The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice
Daiju Fukuda et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Direct Renin Inhibitors as a New Therapy for Hypertension
Randy L. Webb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Impact of Olmesartan on Progression of Coronary Atherosclerosis A Serial Volumetric Intravascular Ultrasound Analysis From the OLIVUS (Impact of OLmesarten on progression of coronary atherosclerosis: evaluation by IntraVascular UltraSound) Trial
Atsushi Hirohata et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis
Masataka Sata et al.
JOURNAL OF MEDICAL INVESTIGATION (2010)
Giant Cell Tubulitis With Immune Complex Deposits in a Patient With Lupus Nephritis
Jeffrey B. Hodgin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study
Claudio Ceconi et al.
ATHEROSCLEROSIS (2009)
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
Mohan R. Dasu et al.
ATHEROSCLEROSIS (2009)
Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques
Yiannis S. Chatzizisis et al.
ATHEROSCLEROSIS (2009)
Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation
Daiju Fukuda et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
Hiroshi Kudo et al.
LIVER INTERNATIONAL (2009)
The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
Fabrizio Montecucco et al.
MEDIATORS OF INFLAMMATION (2009)
Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis
M. E. Perry et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice
Erwin Blessing et al.
ATHEROSCLEROSIS (2008)
Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update
B. W. M. Spanier et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2008)
Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats
GoInar Karimian et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis
Andreas J. Flammer et al.
CIRCULATION (2008)
Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects
Seiichiro Kurita et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade
Shan Chen et al.
KIDNEY INTERNATIONAL (2008)
Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment
Hiroyuki Koga et al.
SURGERY (2008)
Role of the renin-angiotensin system in vascular inflammation
Chiara Marchesi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Decreased infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the anti-atherogenic effects of losartan
Hong-Xin Xu et al.
ACTA CARDIOLOGICA (2007)
Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice
Jose W. A. van der Hoorn et al.
JOURNAL OF HYPERTENSION (2007)
Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats
Koji Fujita et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation - Synergism of TLR2 and TLR4
Masakazu Shinohara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides:: The discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets
Juergen Maibaum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition
Ariel U. Spencer et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis - In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis
A. Price et al.
ARTHRITIS AND RHEUMATISM (2007)
Captopril, an angiotensin-converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9
Ping Chen et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction - An analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
J McMurray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits
M Kato et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
The effect of angilotensin-converting enzyme inhibitors on experimental colitis in rats
N Jahovic et al.
REGULATORY PEPTIDES (2005)
Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice
K Sagawa et al.
ARTHRITIS AND RHEUMATISM (2005)
Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril
WX Zhang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Influence of the angiotensin converting IR enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis
V Mitrovic et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2005)
Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis
V Çobankara et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats
T Yamada et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Severe and steroid-resistant Crohn's disease
P Michetti et al.
DIGESTION (2005)
Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis
MT Nurmohamed et al.
DRUGS (2005)
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation
V da Cunha et al.
ATHEROSCLEROSIS (2005)
Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis
C Grothusen et al.
ATHEROSCLEROSIS (2005)
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis
N Dalbeth et al.
RHEUMATOLOGY (2005)
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats
S Leh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Prevention of fibrosis in experimental colitis by captopril:: the role of TGF-β1
D Wengrower et al.
INFLAMMATORY BOWEL DISEASES (2004)
Angiotensin receptor blockade decreases markers of vascular inflammation
M Graninger et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis - Principal results of PHYLLIS - A randomized double-blind trial
A Zanchetti et al.
STROKE (2004)
The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis
SW Tsang et al.
REGULATORY PEPTIDES (2004)
Direct evidence of leukocyte adhesion in arterioles by angiotensin II
A Alvarez et al.
BLOOD (2004)
Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan
JB Ge et al.
ATHEROSCLEROSIS (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis
Z Li et al.
HYPERTENSION (2004)
Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study
KK Koh et al.
ATHEROSCLEROSIS (2004)
Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model
MT Johnstone et al.
CIRCULATION (2004)
The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-alpha
M Shimozawa et al.
REDOX REPORT (2004)
Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats
T Yamada et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury
R Chen et al.
HYPERTENSION (2003)
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
C Zoja et al.
KIDNEY INTERNATIONAL (2003)
Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury
N Werner et al.
CIRCULATION RESEARCH (2003)
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats
A Kuno et al.
GASTROENTEROLOGY (2003)
Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits
MP Oubina et al.
CLINICAL SCIENCE (2003)
Mechanisms underlying the ameliorative property of lisinopril in progressive mesangioproliferative nephritis
T Shinosaki et al.
NEPHRON (2002)
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation)
ST Rahman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Epidemiology and genetics of rheumatoid arthritis
Alan J. Silman et al.
ARTHRITIS RESEARCH & THERAPY (2002)
Angiotensin II receptor antagonists role in arterial hypertension
R Hernandez-Hernandez et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis
T Hayek et al.
ATHEROSCLEROSIS (2002)
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
S Navalkar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT1 and AT2 receptor-mediated P-selectin upregulation
L Piqueras et al.
CIRCULATION (2000)
Effects of captopril on interleukin-6, leukotriene B4, and oxidative stress markers in serum and inflammatory exudate of arthritic rats:: Evidence of antiinflammatory activity
AM Agha et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
A Daugherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
WB Strawn et al.
CIRCULATION (2000)
Enhanced atherosclerosis and kidney dysfunction in eNOS-/-Apo-/- mice are ameliorated by enalapril treatment
JW Knowles et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
